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The auditory system is responsible for the perception of sound stimuli.
Sound information is transmitted from the cochlea in the inner ear to the
cochlear nucleus via spiral ganglion neurons (SGNs). SGNs innervate
the cochlear nucleus (CN) in a tonotopic fashion, meaning the neuronal
connectivity is organized by frequency response. SGNs responding to
high frequency sounds at the base of the cochlea project their auditory
nerve fibers (ANFs) to the dorsal portions of three subdivisions of the CN,
the dorsal cochlear nucleus (DCN), the posteroventral cochlear nucleus
(PVCN), and the anteroventral cochlear nucleus (AVCN). In contrast,
SGNs that convey information of low frequency sounds at the cochlear
apex send their fibers to the ventral parts of the DCN, PVCN, and the
AVCN, forming isofrequency bands where nearby CN neurons have
similar frequency responses (Fig. 1). Despite its importance in auditory
functions, the molecular mechanisms that underlie the establishment of
this tonotopic map remain elusive.
Ephrins and Eph receptors are cell-cell recognition molecules that play
important roles in axon pathfinding and targeting during neural
development. 16 known Eph receptors constitute the largest known
family of receptor tyrosine kinases, which are divided into two
subclasses: 10 EphAs and 6 EphBs. They interact with ephrin ligands.
The ephrin ligands are also divided into two subclasses: 5 ephrin-As and
3 ephrin-Bs. Ephrin-As are anchored to the plasma membrane with a
glycosylphosphatidylinositol (GPI) anchor. In contrast, ephrin-Bs possess
a single-pass hydrophobic transmembrane domain and a short, highly
conserved cytoplasmic tail. Although Ephs are referred to as receptors
and ephrins are considered ligands, these proteins have the potential for
bidirectional signaling. During reverse signaling, the Eph protein acts as
the ligand and the ephrin functions as the receptor. As the ephrins and
Ephs are expressed on the cell surface, activation of Ephrin-Eph
signaling only occurs at sites of close cell-cell interaction, allowing highly
specific spatial instruction. Previous studies have shown the involvement
of Eph receptors and ephrin ligands in the developments of topographic
maps in other sensory systems (Cramer et al.). To this reason, we are
interested to study whether these proteins could play a role in regulating
tonotopic map formation in the auditory system. We started with
screening expression of ephrin-As in the developing CN.
Figure 1 Schematic drawing of tonotopic connectivity between the cochlea of
the cochlear nucleus. Only the anteroventral cochlear nucleus (AVCN) is shown.
The posteroventral cochlear nucleus (PVCN) and dorsal cochlear nucleus (DCN)
also follow a similar tonotopic connectivity.
Experimental Procedures
RNAScope® in situ hybridization
In situ hybridization was performed using RNAscope® 2.5 HD Duplex
Assay or RNAscope 2.5 HD Assay – RED according to Advanced Cell
Diagnostics’ instruction. Probes used are ephrin-A1 (Cat No. 428621),
ephrin-A2 (Cat No. 507481-C2), ephrin-A3 (Cat No. 473971), ephrin-A4
(Cat No. 487621-C2), ephrin-A5 (Cat No. 316641-C2), c-fos (Cat No.
316921), EphA4 (Cat No. 419081), and EphA7 (Cat No. 458661). After in
situ hybridization, the tissues were counter-stained with DAPI or TuJ1 to
reveal the cellular structure or to mark the SGNs or CN.
Ephrin-A3 stripe assay
Coverglasses with ephrin-A3-Fc stripes were prepared as described by Treffy
et al.. Briefly, 22-mm coverslips were first coated with poly-D-lysine. Silicon
manifolds with 90-μm channels purchased from Dr. Martin Bastmeyer were
applied to polylysine-treated coverglasses. Solutions for the first and second
stripes were prepared as described in the figure legend. For experimental
coverglasses, first stripe solutions contained 2-40 μg ephrin-A3-Fc (R&D
Systems); for control coverglasses, first stripe solutions containd human IgG-
Fc (MilliporeSigma).
NeuroVue labeling from cochlea to the AVCN
NeuroVue labeling was performed as described by Karmakar et al.. NeuroVue
stripes coated with distinct dyes (Red FS-1002, Maroon FS-1001, Molecular
Targeting Technologies) were inserted into different turns of the E18.5 cochlea.
The heads were incubated for 10 days. 60 μm sections anterior to eighth
nerve root were identified as AVCN, collected, and counterstained with anti-
NeuN. ImageJ was used to calculate areas in the AVCN and angular spread of
dyes in the cochlea. θmb or θa is the angular spread of dyes in the mid-basal or
apical cochlear turn. Smb or Sa is the AVCN area innervated by NeuroVue-
labeled ANFs from mid-basal or apical cochlear turns; SAVCN is the total AVCN
area. For quantification, the ratio for mid-basal and apical ANF tracing were
calculated as (Smb/SAVCN × 100)/θmb and (Sa/SAVCN × 100)/θa respectively.
c-fos induction assay after pure tone stimulation
c-fos activation after pure tone stimulation was performed as described by
Karmakar et al.. Briefly, mice were kept silence in an anechoic chamber (ENV-
022SD, Med Assocaites) for an hour, followed by free field tone pips (16 kHz
and/or 8 KHz) at 75 dB SPL for 90 min. Tones were delivered using TDT
System 3 with Crown DCi 2|300 amplifier and Pyramid TW57 speaker in a
custom-made chamber. Stimuli were calibrated with the PCB 378C01 ¼ inch
free-field microphone. After tone exposure, animals were transcardially
perfused. 30 μm AVCN sections were collected and c-fos activation was
detected by in situ hybridization.
Recordings of auditory brainstem responses (ABRs)
ABRs were recorded using TDT System 3 according to manufacturer's instruction.
Acousticstartleresponse(ASR)-basedassaysforevaluatingfrequencydiscrimination
ASR-based procedures were conducted as described by Clause et al. with
semi-custom-made apparatus. The audio files were programmed using Audacity
software and saved as WAV files. Auditory stimulation was delivered through a
RME ADI-2 Pro FS AD/DA Converter with the Crown DCi 2|600 amplifier and a
Visaton TL 16 H super tweeter and calibrated using the PCB 378C01 ¼ inch
free-field microphone. Animals were habituated for three days prior to the test.
An animal restrainer (ENV-263A, Med Assocaites) was placed in the cage on
the first day. On the second day, each animal was placed in the restrainer for 25
minutes inside the anechoic chamber. On the third day, a 70 dB SPL 16-kHz
tone was presented to the animal for 25 min from the tweeter placed 10 cm in
front of the animal. At the start of the trials, animals were allowed to acclimate to
the 16 kHz background tone for five min in the restrainer. ASRs were recorded
on a load-cell platform assembly with an amplifer (PHM-255A and PHM-250B,
Med Assocaites) using Advanced Startle software (SOF-828, Med Assocaites).
The recording traces were exported and analyzed in Microsoft Excel.
Results
Figure 2 Expression of ephrin-As in the E15.5 or E17.5 mouse CN.
(A-H) The expression levels of ephrin-As in the CN were detected by RNAScope® in situ
hybridization using an HRP-based chromogen (blue) or an AP-based chromogen (red). Only VCN
or AVCN are shown and outlined with magenta dashed lines. Ephrin-A1 is not expressed in the CN
and ephrin-A4 is expressed in the eighth nerve but not inside the CN (not shown). Ephrin-A2 and -
A5 are expressed at low levels in the developing VCN/AVCN (A-B, E-F). Ephrin-A3 is expressed at
a higher level in a ventral to dorsal gradient in the developing VCN/AVCN. The specificity of ephrin-
A3 probes was validated by a negative signal on sections from ephrin-A3-/- mice. ChP: Choroid
plexus of 4th ventricle; 8n: eighth nerve; vg: vestibular ganglion. The axis in (A) indicates the
orientation of all the sections in the figure. D, dorsal; M, medial. Scale bar in (H): 200 µm.
Figure 3 Ephrin-A3 forward signaling
repels central processes of auditory nerve
fibers (ANFs) in a temporal-dependent
gradient.
(A andB) An explant fromthebasal turnofan
E17.5 cochlea was cultured on the stripes
containing pre-clustered ephrin-A3-Fc (40
μg/ml, shown in pseudo-colored blue) for 36
hours. The cochlear explant was stained with
anti-Myosin-6 to mark the developing auditory
hair cells (green, arrowheads in A) and anti-
neurofilament/GAP43 to reveal growing
ANFs (magenta). (B) is the high magnification
of the boxed region in (E). In this culture
system, the peripheral processes of ANFs
were still preserved but their staining intensity
was much weaker than the staining intensity
of the central processes. The peripheral
processes could only be visualized at high
magnification (>600X) as shown in (B). This
allows us to easily distinguish the central
processes of ANFs on the stripes from their
peripheral processes and use this explant
system to determine the response of central
processes of ANFs to ephrin-A3 on the stripe
assay. cANF: central processes of ANFs;
pANF: peripheralprocessesofANFs.
IC-J) Explants from E15.5 or E17.5 apical cochlear turns were cultured on the stripes containing different
concentrations of pre-clustered ephrin-A3-Fc. In control cultures both stripes contained pre-clustered
unconjugated human-IgG Fc (40 μg/ml) but the first strip was pre-clustered with an Alexa-488-goat anti-human
IgG-Fc(shownasgreenstripes)whereasthesecondstripewaspre-clusteredwithanunlabeledgoatanti-human
IgG-Fc (shown as uncolored stripes). In ephrin-A3 cultures, the first stripe contained various concentration of
ephrin-A3-Fc (10 μg/ml A3-Fc + 30 μg/ml unconjugated human-IgG-Fc, 20 μg/ml A3-Fc + 20 μg/ml
unconjugated human-IgG-Fc, or 40 μg/ml A3-Fc) pre-clustered with an Alexa-488-goat anti-human IgG-Fc
(shown inpseudo-coloredmagenta)and thesecondstripewas thesameas in thecontrol cultures.Nobiaswas
observed in the E15.5 and E17.5 control cultures (C, D). ANFs show different repulsive responses to ephrin-A3
during development. At E15.5,ANFs were already strongly repelled by stripes containing 10μg/ml ephrin-A3-Fc
(C, E, G, I). In contrast, E17.5 ANFs can only be repelled by stripes when the concentration of ephrin-A3-Fc
increased to 20 or 40μg/ml (D, F, H, J). Scale bar in (J), 240μm for (A, C-J) and 40μm for (B). (K-N) Statistical
analysis of stripe assays indicates that ANFs show a temporal-dependent reduction of repulsive responses to
ephrin-A3.BothapicalandbasalANFsatE15.5werestrongly repelledbystripespreparedwith10μg/mlephrin-
A3-Fc.AtE17.5,basalANFsonlyshowedrepulsiontostripescontaining40μg/mlephrin-A3-FcandapicalANFs
were weakly repelled by stripes containing 20 μg/ml ephrin-A3-Fc or repelled by stripes containing 40 μg/ml
ephrin-A3-Fc. Numbers on the bar indicate the sample size. Means ± SDs are shown. ns: not statistically
significant,*:P<0.05,**:P<0.01,***:P<0.001,Two-wayANOVAwithpost-hocWelch'sunequalvariancest-test.
Figure 4 Reduced precision of tonotopic
organization of ANF inputs in the ephrin-A3-/-
mutant AVCN.
(A and B) NeuroVue labeling of mid-basal
(magenta) and apical cochlear turns (green), and
their NeuroVue tracing in the AVCN (magenta
from mid-basal ANFs and green from apical
ANFs) in E18.5 control and ephrin-A3-/- mice. The
cochlea and AVCN were counter-stained with
anti-NeuN to reveal the cellular structure. The
NeuroVue-labeled ANF axon terminals from mid-
basal or apical cochlear turns target distinct
regions along the tonotopic axis of the AVCN in
both control and ephrin-A3-/- mice. However, the
dye tracing from ephrin-A3-/- ANFs in the AVCN
was more spread out when compared to the
tracing from control ANFs. sg: spiral ganglion; θmb
or θa: the angular spread of NeuroVue dyes in the
mid-basal or apical cochlear turn; Smb or Sa: the
AVCN area innervated by NeuroVue-labeled
ANFs from mid-basal or apical cochlear turns;
SAVCN: total AVCN area. Scale bar in (B), 300 μm
for cochleae and 100 μm for AVCN. (C) Welch's
unequal variances t-test shows that ephrin-A3-/-
ANFs innervate a significant larger region in the
AVCN than control ANFs. Mid-basal ephrin-A3-/-
ANFs target ~24% more area and apical ephrin-
A3-/- ANFs target ~70% more area in the mutant
AVCN when compared to the AVCN area
targeted by controlANFs.
Figure 5 Broader tonotopic
bands of c-fos activation in the
AVCN upon pure tone stimulation
and impaired tone discrimination
in ephrin-A3-/- mutant mice.
(A-F) c-fos-activated AVCN neurons
detected by RNAScope® in situ
hybridization in response to
stimulation of a single 16-kHz pure
tone, a single 8-kHz pure tone, or
simultaneous 16- and 8-kHz dual
tones in control and ephrin-A3-/-
mutant AVCN. c-fos+ bands in
AVCN after 16-kHz stimulation or 8-
kHz stimulation were broader in
ephrin-A3-/- mutants than in controls
(A-D). Upon 16-kHz and 8-kHz dual
tone exposure, a separation region
between the two c-fos-activated
bands can be readily detected in
the control animals, whereas no
clear band separation is observed
in ephrin-A3-/- mutant animals (E,
F). Scale bar in (F): 200 µm.
Figure 6 Ephrin-A3-/- mutants show a delayed wave II in auditory brainstem
responses (ABRs).
(A) Representative ABR recordings from a 6-week-old littermate control (blue
traces) and ephrin-A3-/- mutant (magenta traces) exposed to 8 kHz, 11.3 kHz,16
kHz, or 22.6 kHz pure tone stimuli at intensity of 90 dB sound pressure level
(SPL). Roman numerals mark the ABR waves. Wave I of ABRs are normal but
Wave II are delayed in the ephrin-A3-/- mutant compared to its control littermate.
(B) Average ABR thresholds for 7 littermate controls (blue) and 8 ephrin-A3-/-
mutants (magenta) across frequency. No significant difference was observed
between controls and ephrin-A3-/- mutants (Welch's unequal variances t-test,
P>0.1 at all frequencies). (C and D) Average Wave I and Wave II amplitudes for 7
littermate controls (blue) and 8 ephrin-A3-/- mutants (magenta) in response to 8
kHz, 11.3 kHz,16 kHz, or 22.6 kHz pure tone stimuli at intensity of 90 dB SPL.
Wave I and Wave II of ABRs reflects the synchronous activity of spiral ganglion
neurons in the cochlea and bushy cell neurons in the AVCN respectively. No
significant difference of Wave I and Wave II amplitudes was observed between
controls and ephrin-A3-/- mutants (Welch's unequal variances t-test, P>0.4 for
both Wave I and Wave II at all frequencies). (E and F) Average Wave I and Wave
II latencies for 7 littermate controls (blue) and 8 ephrin-A3-/- mutants (magenta) in
response to 8 kHz, 11.3 kHz,16 kHz, or 22.6 kHz pure tone stimuli at intensity of
90 dB SPL. No significant difference of Wave I latencies was observed between
controls and ephrin-A3-/- mutants (Welch's unequal variances t-test, P>0.1 at all
frequencies). However, Wave II in ephrin-A3-/- mutants were significantly delayed
when compared to littermate controls (Welch's unequal variances t-test, *: P
<0.05, **: P<0.01). Means ± SDs are shown in (B-F).
Numbers on the bar indicate the sample size. Means ± SDs are shown. *: P < 0.05, ***: P<0.001.
(G) Quantification of c-fos-activated areas or band separation areas normalized to
total AVCN areas in response to stimulation of a single 16-kHz tone, a single 8-kHz
tone, or simultaneous 16- and 8-kHz dual tones in control and ephrin-A3-/- mutant
AVCN. Numbers on the bar indicate the sample size. Means ± SDs are shown. **: P
<0.01, ***: P<0.001, Welch's unequal variances t-test.
Figure 7 Ephrin-A3-/- mutants show impaired prepulse inhibition (PPI) of
acoustic startle response (ASR) for detecting changes in sound frequencies.
(A) Trial schematic for the acoustic startle-based sound discrimination assay. ISI:
inter-stimulus interval; F1: background frequency; F2: pre-pulse frequency; ΔF:
frequency change. (B) Background noise in the anechoic chamber. (C) White noise
at 120 dB SPL for the startle stimulus. (D and E) 16 kHz tone at 70 dB SPL was
used as the background frequency and 15.92, 15.68, 15.47, 15.2, 14.4, 13.34, and
12 kHz tones at 70 dB SPL were used as the prepulse frequency tones. Only the
12 kHz prepulse tone was shown. (F-K) Representative recording traces of
baseline activity and acoustic startle responses from littermate controls (blue) and
ephrin-A3-/- mutants (magenta). Baseline traces represent the force measured on
the loadcell platform during a 500-ms recording period immediately before the
prepulse. ASR traces represent vertical force generated from the ASR measured
during a second 500-ms recording period starting at the onset of the startle
stimulus. Both the positive and negative directions of the maximum force were
recorded and reported as the ASR. Scale bar, 1.0 arbitrary unit of force, 100 ms.
Both control and ephrin-A3-/- mice show a normal ASR in response to the startle
stimulus. A change from the 16 kHz background tone to prepulse tones (15.47 kHz,
3.3% change or 12 kHz, 25% change) before the startle stimulus inhibited the ASR
in both control and ephrin-A3-/- mice. However, the amount of inhibition elicited by
the small 3.3% negative frequency change (16 kHz to 15.47 KHz) was less in
ephrin-A3-/- mutants when compared to control. The large 25% frequency change
elicits similar inhibition between control and ephrin-A3-/- mice. (L) Average ASR
amplitudes for 8 controls (blue) and 6 ephrin-A3-/- mutants (magenta) for each trial
type. Means ± SDs are shown. No significant difference of ASR amplitudes was
observed between controls and ephrin-A3-/- mutants in response to the startle-only
stimulus (control vs. ephrin-A3-/-: 1.98 ± 0.13 vs. 2.03 ± 0.11 arbitrary units; P =
0.56, Welch's unequal variances t-test). The ASR magnitude elicits by small
negative frequency changes (0.5-5%) was significant smaller in controls than in
ephrin-A3-/- mutants (ns: not statistically significant, *: P < 0.05, Two-way ANOVA
with post-hoc Welch's unequal variances t-test). (M) Average percent inhibition of
the ASR elicited by prepulse frequency changes at various magnitudes for 8
controls (blue) and 6 ephrin-A3-/- mutants (magenta). Means ± SDs are shown.
Ephrin-A3-/- mutants showed significant decreased and impaired prepulse inhibition
for small negative frequency changes (0.5-5%), indicating that they have deficits in
the ability to detect small frequency changes. Arrows indicate discrimination
threshold, the smallest frequency change that elicited a significant inhibition of the
ASR [p < 0.05, one-way Welch's unequal variances t-test compared to zero (no
frequency change)]. Ephrin-A3-/- mutants showed elevated frequency discrimination
threshold, indicating that they have impaired frequency difference limens.
Figure 8 Potential ephrin-A3
receptors are expressed in
developing spiral ganglion
neurons.
Expression of EphA4 and
EphA7 receptors in E15.5 or
E17.5 cochleae were detected
by RNAScope® in situ
hybridization using an AP-
based chromogen (red). The
cochlear sections were co-
stained with TuJ1 to mark the
spiral ganglion (sg). The spiral
ganglion was outlined with
dashed lines based on TuJ1
staining. Both EphA4 and
EphA7 receptors are expressed
in developing spiral ganglion
neurons. c: cochlear duct. The
axis in (A) indicates the
orientation of all the sections in
the figure. D, dorsal; L, lateral.
Scale bar in (D’): 200 µm.
Figure 9 Proposed model for ephrin-A3’s role in tonotopic map
formation and sound discrimination.
During embryonic development, ephrin-A3 is expressed in the cochlear
nucleus (CN) in a ventral to dorsal gradient. Neurogenesis of spiral
ganglion neurons (SGNs) occurs in a basal to apical progression along the
cochlea. ANFs of the early-born SGNs from basal and middle regions of
the cochlea innervate the CN 1-3 days earlier than ANFs of the late-born
apical SGNs. These early-arriving ANFs are repelled by a high-
concentration of ephrin-A3 from the ventral side and innervate more dorsal
region of the CN. 2-3 days later, the repulsive response of ANFs to ephrin-
A3 decreases, allowing late-arriving apical ANFs to target to the ventral
region of the CN. When the auditory system matures, the cochlea and CN
establish a normal cochleotopic arrangement of neuronal connectivity
where basal ANFs project to the dorsal part of the CN and apical ANFs
target to the ventral side of the CN, forming precise isofrequency bands
where nearby CN neurons are activated by stimulation of a similar
frequency. This tonotopic organization allowing animals to have sound
discrimination even with subtle frequency changes. In ephrin-A3-/- mutants,
early-born early-arriving ANFs from basal and middle regions of the
cochlea may start to innervate more ventral region of the cochlear nucleus
due to a lack of ephrin-A3 repulsion from the ventral end, causing an
abnormal innervation of ANFs. This abnormal innervation may eventually
lead to a degraded, less accurate tonotopic map when the animal matures,
resulting in broader tonotopic bands and impaired ability to detect small
frequency changes.
Conclusions
1. Ephrin-A3 is expressed in a ventral to dorsal
gradient in the developing cochlear nucleus.
2. ANFs show a temporal-dependent reduction of
repulsive responses to ephrin-A3 during
development.
3. Mice lacking ephrin-A3 show broader tonotopic
bands and impaired precision of tonotopic
maps in the AVCN.
4. Mice lacking ephrin-A3 fail to discriminate
sounds with small frequency changes.
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